Neurological Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neurological Disorders stocks.

Neurological Disorders Stocks Recent News

Date Stock Title
May 16 IONS Biogen also drops collaboration with Ionis on Angelman syndrome candidate
May 16 IONS Biogen and Ionis drop ALS candidate after trial setback
May 16 IONS Biogen, Ionis shelve ALS drug following study failure
May 16 IONS REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
May 16 IONS Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16 IONS Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16 IONS Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
May 15 AEMD Aethlon Medical announces pricing of $4.7 million public offering
May 15 AEMD Aethlon Medical Announces Pricing of $4.7 Million Public Offering
May 15 ACAD Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
May 15 AEMD Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15 IONS Ionis to host 2024 virtual Annual Meeting of Stockholders
May 15 PMN ProMIS Neurosciences GAAP EPS of -$0.19
May 14 PMN ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
May 14 PRTA News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts
May 13 AEMD AEMD: Data From In Vitro Study Supports Advancing Planned Oncology Clinical Trial
May 12 ACAD Cantor picks 14 undervalued biotech stocks worth a second look
May 12 PRTA Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest Results
May 11 ACAD Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 11 RLMD Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript
Neurological Disorders

Neurological disorders are conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. These disorders can affect how the body functions, including movement, speech, and memory. Examples of neurological disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, epilepsy, and migraine.

Browse All Tags